Quanterix (QTRX) EBT Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -8.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.78% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 103.34% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 74.66% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.02% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 54.33% |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn | 25.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.06% |
| Dec 31, 2025 | -95.70% |
| Sep 30, 2025 | -338.56% |
| Jun 30, 2025 | -313.84% |
| Mar 31, 2025 | -113.21% |
| Dec 31, 2024 | -34.18% |
| Sep 30, 2024 | -26.02% |
| Jun 30, 2024 | -36.76% |
| Mar 31, 2024 | -53.95% |
| Dec 31, 2023 | 51.94% |
| Sep 30, 2023 | 82.15% |
| Jun 30, 2023 | 80.14% |
| Mar 31, 2023 | 60.63% |
| Dec 31, 2022 | -0.50% |
| Sep 30, 2022 | -133.41% |
| Jun 30, 2022 | -125.78% |
| Mar 31, 2022 | -78.58% |
| Dec 31, 2021 | -80.55% |
| Sep 30, 2021 | -847.04% |
| Jun 30, 2021 | 3.77% |
| Mar 31, 2021 | 13.53% |
| Dec 31, 2020 | 10.13% |
| Sep 30, 2020 | 120.93% |
| Jun 30, 2020 | -16.89% |
| Mar 31, 2020 | -25.06% |
| Dec 31, 2019 | -150.01% |
| Sep 30, 2019 | -30.53% |
| Jun 30, 2019 | -43.54% |
| Mar 31, 2019 | -30.28% |
| Dec 31, 2018 | 411.96% |
| Sep 30, 2018 | -19.88% |
| Jun 30, 2018 | -13.51% |
| Mar 31, 2018 | -14.12% |